New blood test shows promising potential for early cancer detection

A new experimental blood test capable of detecting six types of cancer at an early stage has shown encouraging results in research supported by the NIHR. 

The study found that the liquid biopsy test, named TriOx, can improve the detection of trace amounts of cancer DNA in the blood. This could enable earlier diagnosis and reliably distinguish between patients with cancer and those without.

Click here to access the article.